During the past decade, Ospedale Santa Maria delle Croci conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 25 clinical trials were completed, i.e. on average, 37.3% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 19 clinical trials were completed. i.e. 48.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Santa Maria delle Croci" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 10 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 7 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Takeda" with 5 trials sponsored. Other sponsors include 79 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Santa Maria delle Croci" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 3 trials as a collaborator, "Clinical Research Technology S.r.l." with 3 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator and "Foundation Medicine" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Santa Maria delle Croci" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Metastatic Breast Cancer" (5 trials), "Acute Myeloid Leukemia" (4 trials), "Breast Cancer" (4 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "Ospedale Santa Maria delle Croci" in a lesser frequency.

Most popular intervention types in "Ospedale Santa Maria delle Croci" are "Drug" (92 trials), "Other" (10 trials), "Procedure" (6 trials), "Biological" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (11 trials), "Placebo" (9 trials), "Pemetrexed" (8 trials), "Amivantamab" (6 trials) and "Lazertinib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Santa Maria delle Croci" are 103 trials for "All" genders, 11 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Santa Maria delle Croci". undefined are not yet recruiting, 26 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Ospedale Santa Maria delle Croci, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Santa Maria delle Croci, 11 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".